Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
35.15
-0.21 (-0.59%)
Sep 29, 2026, 9:32 AM EDT - Market open
Genmab Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Genmab stock has a consensus rating of "Strong Buy" and an average price target of $39.14. The average 1-year stock price forecast is 11.35% higher than the current stock price, while the lowest is $32 (-8.96%) and the highest is $45 (+28.02%).
Price Target: $39.14 (+11.35%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Genmab stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 10 | 10 | 10 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $40 | Buy | Reiterates | $40 | +13.80% | Sep 14, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 12, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 11, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $40 → $42 | Buy | Maintains | $40 → $42 | +19.49% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
4.59B
from 3.72B
Increased by 23.39%
Revenue Next Year
5.33B
from 4.59B
Increased by 16.04%
EPS This Year
1.31
from 1.77
Decreased by -26.23%
EPS Next Year
1.73
from 1.31
Increased by 31.96%
EPS and Forward PE are based on non-GAAP adjusted numbers.